Delivery Order SPE2DB20D9127-SPE2DB24FPQF7
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 3.5 mg vials of the pharmaceutical product VELCADE with a potential value of $2,331.44. The delivery order has a completion date of February 12, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of brand and generic prescription and over-the-counter drug...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 3.5 mg vials of the pharmaceutical drug VELCADE. The $13,988.64 contract has a completion date of March 7, 2024 and is not set aside for any special designation. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds a larger indefinite delivery contract with DLA, valued up to $4,999,999 through 2025, to deliver a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,988.64 firm fixed-price contract is for the delivery of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of VELCADE 3.5 mg vials, with a potential value of $10,290.87. The contract has a completion date of January 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that provides a wide range of pharmaceutical and medical products to the federal government, primarily the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,758.60 delivery order is for the supply of VELCADE 3.5 MG VIALS, a specialty oncology medication. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a...
- This is a $23,314.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of VELCADE 3.5 MG VIALS and has a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical...
- This firm fixed-price delivery order, valued at $34,971.60, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of VELCADE 3.5 MG VIALS to the Defense Logistics Agency (DLA), Medical Supply Chain division, under the SPE2DX24F6XFU indefinite delivery contract. DMS Pharmaceutical Group holds a larger indefinite delivery contract (SPE2DB) with the DLA, valued up to $499,999,999, to provide a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $23,314.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has a period of performance through June 24, 2024, is for the supply of VELCADE 3.5 MG VIALS to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $23,314.40 firm-fixed-price contract is for the delivery of VELCADE 3.5 mg vials to support the recurring medical supply needs of military health facilities. The award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,151.45 contract is for the delivery of VELCADE 3.5 MG VIALS, a specialized oncology medication, with a period of performance through December 22, 2023. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB24FPQF7Delivery Order
This firm-fixed-price delivery order contract, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of VELCADE 3.5 MG VIALS to support the pharmaceutical supply needs of military health facilities. The contract has a ceiling value of $23,314.40 and a period of performance through April 2024. DMS Pharmaceutical Group holds an indefinite delivery vehicle (IDV) contract with DLA, valued at up to $4,999,999 through 2025, which enables the agency to issue delivery orders for a wide range of pharmaceutical products to fulfill the recurring medical supply requirements of military healthcare facilities globally. This delivery order is not associated with any set-aside program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.3k | 3/27/24 |